The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Cartt Stephen Lahue since 2005.
The trader's CIK number is 1321073.
At the time of the last reporting, Cartt Stephen Lahue was the See Remarks of Asterias Biotherapeutics, Inc.. (stock ticker symbol AST).
Also see all insider trading activities at Asterias Biotherapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | AST | 60,000 | $170,530 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | QCOR | 10,000 | $241,700 | 0 | $0 | 0 | $0 |
| 2011 | QCOR | 0 | $0 | 505,509 | $16,218,695 | 505,509 | $939,328 |
| 2009 | QCOR | 0 | $0 | 250,000 | $1,520,250 | 250,000 | $115,000 |
| 2008 | QCOR | 0 | $0 | 300,000 | $1,881,000 | 200,000 | $92,000 |
| 2007 | QCOR | 0 | $0 | 124,602 | $729,110 | 0 | $0 |
| 2005 | QCOR | 35,400 | $22,656 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | BTX | 75,000 | $210,050 | 0 | $0 | 0 | $0 |
1. Asterias Biotherapeutics, Inc. (AST)
2. Questcor Pharmaceuticals Inc (QCOR)
3. Lineage Cell Therapeutics, Inc. (BTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-06-30 | AST | Buy | 10,000 | 2.40 | 23,980 |
| 2016-06-10 | AST | Buy | 50,000 | 2.93 | 146,550 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-11-02 | QCOR | Buy | 10,000 | 24.17 | 241,700 |
| 2011-11-08 | QCOR | Option Ex | 8,100 | 5.09 | 41,229 |
| 2011-11-08 | QCOR | Sale | 8,100 | 42.75 | 346,275 |
| 2011-10-28 | QCOR | Option Ex | 139,286 | 2.86 | 398,079 |
| 2011-10-31 | QCOR | Sale | 25,000 | 42.60 | 1,065,000 |
| 2011-10-31 | QCOR | Option Ex | 25,000 | 5.09 | 127,250 |
| 2011-10-28 | QCOR | Sale | 139,286 | 41.36 | 5,760,868 |
| 2011-08-15 | QCOR | Option Ex | 47,155 | 1.40 | 66,017 |
| 2011-08-15 | QCOR | Sale | 47,155 | 31.50 | 1,485,382 |
| 2011-08-10 | QCOR | Option Ex | 25,000 | .98 | 24,500 |
| 2011-08-11 | QCOR | Option Ex | 85,968 | 1.43 | 122,934 |
| 2011-08-10 | QCOR | Sale | 25,000 | 31.00 | 775,000 |
| 2011-08-11 | QCOR | Sale | 85,968 | 31.09 | 2,673,174 |
| 2011-08-04 | QCOR | Option Ex | 25,513 | .98 | 25,002 |
| 2011-08-04 | QCOR | Sale | 25,513 | 30.17 | 769,727 |
| 2011-05-13 | QCOR | Option Ex | 70,400 | .81 | 56,812 |
| 2011-05-13 | QCOR | Sale | 70,400 | 22.73 | 1,600,192 |
| 2011-05-16 | QCOR | Option Ex | 79,087 | .98 | 77,505 |
| 2011-05-16 | QCOR | Sale | 79,087 | 22.04 | 1,743,077 |
| 2009-08-04 | QCOR | Sale | 100,000 | 6.12 | 612,000 |
| 2009-08-03 | QCOR | Sale | 150,000 | 6.05 | 908,250 |
| 2009-08-04 | QCOR | Option Ex | 100,000 | .46 | 46,000 |
| 2009-08-03 | QCOR | Option Ex | 150,000 | .46 | 69,000 |
| 2008-12-10 | QCOR | Option Ex | 100,000 | .46 | 46,000 |
| 2008-12-10 | QCOR | Sale | 100,000 | 9.50 | 950,000 |
| 2008-05-30 | QCOR | Sale | 100,000 | 5.30 | 530,000 |
| 2008-05-30 | QCOR | Option Ex | 100,000 | .46 | 46,000 |
| 2008-03-18 | QSC | Sale | 100,000 | 4.01 | 401,000 |
| 2007-12-10 | QSC | Sale | 49,602 | 6.00 | 297,860 |
| 2007-12-12 | QSC | Sale | 75,000 | 5.75 | 431,250 |
| 2005-10-31 | QSC | Buy | 35,400 | .64 | 22,656 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-08-14 | BTX | Buy | 18,400 | 2.65 | 48,760 |
| 2015-08-17 | BTX | Buy | 39,400 | 2.83 | 111,462 |
| 2015-08-18 | BTX | Buy | 17,200 | 2.90 | 49,828 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cartt Stephen Lahue (See Remarks of Asterias Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.